Daniel Brennan
Stock Analyst at TD Cowen
(4.96)
# 106
Out of 5,104 analysts
723
Total ratings
59.6%
Success rate
26.3%
Average return
Main Sectors:
Stocks Rated by Daniel Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALMR Alamar Biosciences | Rated: Buy | $34 → $36 | $27.39 | +31.43% | 3 | Nov 4, 2026 | |
| RVTY Revvity | Reiterated: Buy | $175 → $185 | $159.43 | +16.04% | 28 | Nov 4, 2026 | |
| WAT Waters | Reiterated: Buy | $515 → $530 | $467.60 | +13.34% | 31 | Nov 4, 2026 | |
| NEO NeoGenomics | Reiterated: Buy | $19 → $23 | $17.15 | +34.11% | 24 | Oct 29, 2026 | |
| DHR Danaher | Rated: Buy | $255 → $270 | $234.93 | +14.93% | 35 | Oct 22, 2026 | |
| TMO Thermo Fisher Scientific | Rated: Buy | $760 → $810 | $706.16 | +14.70% | 42 | Oct 22, 2026 | |
| A Agilent Technologies | Rated: Buy | $180 → $196 | $177.17 | +10.63% | 42 | Oct 13, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $28 → $32 | $26.71 | +19.81% | 18 | Oct 13, 2026 | |
| AVTR Avantor | Reiterated: Hold | $15 → $17 | $15.65 | +8.63% | 27 | Oct 13, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $30 → $40 | $21.49 | +86.13% | 11 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $36 | $33.22 | +8.37% | 10 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $180 | $143.66 | +25.30% | 9 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $210 → $270 | $226.54 | +19.18% | 46 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $4.5 | $6.02 | -25.25% | 22 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 → $480 | $391.03 | +22.75% | 28 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3 → $3.5 | $3.04 | +15.13% | 19 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $70 | $67.52 | +3.67% | 34 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $8.51 | +29.26% | 17 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $11.30 | +50.44% | 1 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $0.1564 | +539.39% | 13 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.02 | - | 16 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.55 | +17.65% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.97 | - | 15 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $210 | $168.58 | +24.57% | 20 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 → $60 | $63.79 | -5.94% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $18 | $15.79 | +14.00% | 16 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $44 | $50.83 | -13.44% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $71 | $75.61 | -6.10% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $85 | $69.34 | +22.58% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.29 | - | 12 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.70 | - | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $183 | $209.19 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.616 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $112.06 | n/a | 1 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $46.17 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $62 | $7.72 | n/a | 3 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $142.58 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 4 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $465 | $326.29 | n/a | 7 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $880 → $1,139 | $1,723.24 | n/a | 12 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $224 → $275 | $263.79 | n/a | 4 | Apr 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $174 → $232 | $203.11 | n/a | 8 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $52.52 | n/a | 1 | Nov 26, 2013 |
Alamar Biosciences
Nov 4, 2026
Rated: Buy
Price Target: $34 → $36
Current: $27.39
Upside: +31.43%
Revvity
Nov 4, 2026
Reiterated: Buy
Price Target: $175 → $185
Current: $159.43
Upside: +16.04%
Waters
Nov 4, 2026
Reiterated: Buy
Price Target: $515 → $530
Current: $467.60
Upside: +13.34%
NeoGenomics
Oct 29, 2026
Reiterated: Buy
Price Target: $19 → $23
Current: $17.15
Upside: +34.11%
Danaher
Oct 22, 2026
Rated: Buy
Price Target: $255 → $270
Current: $234.93
Upside: +14.93%
Thermo Fisher Scientific
Oct 22, 2026
Rated: Buy
Price Target: $760 → $810
Current: $706.16
Upside: +14.70%
Agilent Technologies
Oct 13, 2026
Rated: Buy
Price Target: $180 → $196
Current: $177.17
Upside: +10.63%
Adaptive Biotechnologies
Oct 13, 2026
Reiterated: Buy
Price Target: $28 → $32
Current: $26.71
Upside: +19.81%
Avantor
Oct 13, 2026
Reiterated: Hold
Price Target: $15 → $17
Current: $15.65
Upside: +8.63%
Biodesix
Oct 13, 2026
Reiterated: Buy
Price Target: $30 → $40
Current: $21.49
Upside: +86.13%
Oct 13, 2026
Reiterated: Buy
Price Target: $30 → $36
Current: $33.22
Upside: +8.37%
Oct 13, 2026
Reiterated: Buy
Price Target: $88 → $180
Current: $143.66
Upside: +25.30%
Oct 13, 2026
Rated: Hold
Price Target: $210 → $270
Current: $226.54
Upside: +19.18%
Oct 13, 2026
Reiterated: Hold
Price Target: $7 → $4.5
Current: $6.02
Upside: -25.25%
Oct 13, 2026
Reiterated: Buy
Price Target: $340 → $480
Current: $391.03
Upside: +22.75%
Oct 13, 2026
Rated: Hold
Price Target: $3 → $3.5
Current: $3.04
Upside: +15.13%
Oct 13, 2026
Reiterated: Hold
Price Target: $47 → $70
Current: $67.52
Upside: +3.67%
Oct 13, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $8.51
Upside: +29.26%
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $11.30
Upside: +50.44%
Aug 13, 2026
Reiterated: Buy
Price Target: $1
Current: $0.1564
Upside: +539.39%
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.02
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $3
Current: $2.55
Upside: +17.65%
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.97
Upside: -
Jul 31, 2026
Rated: Buy
Price Target: $200 → $210
Current: $168.58
Upside: +24.57%
Jul 15, 2026
Reiterated: Hold
Price Target: $43 → $60
Current: $63.79
Upside: -5.94%
Jul 15, 2026
Rated: Buy
Price Target: $10 → $18
Current: $15.79
Upside: +14.00%
Jul 15, 2026
Reiterated: Hold
Price Target: $40 → $44
Current: $50.83
Upside: -13.44%
Jul 15, 2026
Reiterated: Buy
Price Target: $68 → $71
Current: $75.61
Upside: -6.10%
Jul 15, 2026
Reiterated: Buy
Price Target: $55 → $85
Current: $69.34
Upside: +22.58%
Apr 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.29
Upside: -
Feb 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.70
Upside: -
Jul 14, 2025
Reiterated: Hold
Price Target: $183
Current: $209.19
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $2.5
Current: $0.616
Upside: n/a
Apr 27, 2023
Reiterated: Buy
Price Target: $525
Current: $112.06
Upside: n/a
Apr 26, 2023
Reiterated: Buy
Price Target: $45
Current: $46.17
Upside: n/a
Oct 15, 2021
Reiterated: Buy
Price Target: $68 → $62
Current: $7.72
Upside: n/a
Oct 14, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $142.58
Upside: n/a
Oct 14, 2021
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $390 → $465
Current: $326.29
Upside: n/a
May 7, 2021
Reiterated: Sell
Price Target: $880 → $1,139
Current: $1,723.24
Upside: n/a
Apr 23, 2021
Reiterated: Buy
Price Target: $224 → $275
Current: $263.79
Upside: n/a
Mar 1, 2021
Upgraded: Buy
Price Target: $174 → $232
Current: $203.11
Upside: n/a
Nov 26, 2013
Initiated Coverage: Buy
Price Target: $16
Current: $52.52
Upside: n/a